OMOP Concept 37560926
Antineoplastic bispecific antibody
ClassificationDrugHemOnc139671Component Class
Maps from
0
Descendants
49
Valid from
14 Jun 2024
Valid to
31 Dec 2099
OMOP concepts
Concept Lookup Tool
Search 11M+ concepts across SNOMED, RxNorm, ICD-10 & LOINC.
Where it sits in the hierarchy
Ordered by distance - 1 is a direct parent or child.
Broader concepts
(4)Roll up to these when you need a wider cohort.
Narrower concepts
(49)Included automatically when you query with descendants.
- 1amivantamab
- 1Anti-EGFR-HGFR bispecific antibody
- 1Anti-HER2 bispecific antibody
- 1Anti-PD-1-VEGF bispecific antibody
- 2IVONESCIMAB
- 3amivantamab / hyaluronidase Injectable Product
- 3amivantamab / hyaluronidase Injection
- 3amivantamab / hyaluronidase Injection [Rybrevant Faspro]
- 3amivantamab Injectable Product
- 3amivantamab Injectable Solution
- 3amivantamab Injectable Solution [Rybrevant]
- 3amivantamab Injection
- 3amivantamab Injection [Rybrevant]
- 3amivantamab-lpuj 160 MG/ML
- 3amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML [Rybrevant Faspro]
- 3Amivantamab monotherapy
- 3amivantamab-vmjw 50 MG/ML
- 3amivantamab-vmjw 50 MG/ML [Rybrevant]
- 3Carboplatin, Lazertinib, Pemetrexed, Amivantamab
- 3Carboplatin, Pemetrexed, Amivantamab
- 3Lazertinib and Amivantamab
- 3Rybrevant Faspro Injectable Product
- 3Rybrevant Injectable Product
- 410 ML amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection
- 410 ML amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection [Rybrevant Faspro]
- 414 ML amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection
- 414 ML amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection [Rybrevant Faspro]
- 47 ML amivantamab 50 MG/ML Injectable Solution
- 47 ML amivantamab 50 MG/ML Injectable Solution [Rybrevant]
- 47 ML amivantamab-vmjw 50 MG/ML Injection
- 47 ML amivantamab-vmjw 50 MG/ML Injection [Rybrevant]
- 4amivantamab 50 MG/ML Injectable Solution
- 4amivantamab 50 MG/ML Injectable Solution [Rybrevant]
- 4amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection
- 4amivantamab-lpuj 160 MG/ML / hyaluronidase-lpuj 2000 UNT/ML Injection [Rybrevant Faspro]
- 4amivantamab-vmjw 50 MG/ML Injection
- 4amivantamab-vmjw 50 MG/ML Injection [Rybrevant]
- 57 ML amivantamab 50 MG/ML Injectable Solution Box of 1
- 57 ML amivantamab 50 MG/ML Injectable Solution [Rybrevant] Box of 1
- 57 ML amivantamab 50 MG/ML Injectable Solution [Rybrevant] Box of 1 by Janssen
- 57 ML amivantamab 50 MG/ML Injectable Solution [Rybrevant] by Janssen
- 57 ML amivantamab 50 MG/ML Injection Box of 1
- 57 ML amivantamab 50 MG/ML Injection [Rybrevant] Box of 1
- 57 ML amivantamab 50 MG/ML Injection [Rybrevant] Box of 1 by Janssen
- 57 ML amivantamab 50 MG/ML Injection [Rybrevant] by Janssen
- 5amivantamab 50 MG/ML Injectable Solution Box of 1
- 5amivantamab 50 MG/ML Injectable Solution [Rybrevant] Box of 1
- 5amivantamab 50 MG/ML Injection Box of 1
- 5amivantamab 50 MG/ML Injection [Rybrevant] Box of 1
Get this concept via the API
Resolve Antineoplastic bispecific antibody - and every code that maps to it - over HTTPS, against the current vocabulary release. No downloads, no local database.
curl "https://api.omophub.com/v1/concepts/37560926?include_relationships=true" \
-H "Authorization: Bearer $OMOPHUB_API_KEY"Get your free API key3,000 calls/month free · no credit card